AlphaYou
Overview
Key stats
Fundamentals Sep 12- Open
- $517.00
- 52-wk high
- $769.98
- High
- $522.49
- 52-wk low
- $500.61
- Low
- $511.16
- Prev close
- $520.21
- Mkt cap
- $39.76B
- P/E
- 35.6x
- Volume
- 556.5K
- Fwd P/E
- 30.6x
- Beta
- 1.54
- P/S
- 8.7x
- P/B
- 24.8x
- Profit margin
- +25.0%
- Op margin
- +35.0%
- ROE
- +74.2%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 8.1% above what analysts expected.
Earnings per share
$3.95 expected
GAAP EPS was $4.27 and adjusted EPS was $4.07. The analyst basis could not be confirmed, so no beat or miss is shown.
Reports Nov 2, 2026, in 50 days
EPS expected
$3.37 to $3.91
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.11B | $1.09B | $1.14B | $1.22B |
| Cost of what it sold | $421.9M | $432.5M | $418.1M | $437.5M |
| Gross profit | $683.4M | $658.1M | $722.7M | $779.1M |
| What it spent | ||||
| Research and development | $63.4M | $66.8M | $65.8M | $65.4M |
| Sales and admin | $105.9M | $108.6M | $119.1M | $116.8M |
| Other operating costs | $159.2M | $167.1M | $175.3M | $171.3M |
| Total operating expenses | $328.5M | $342.5M | $360.2M | $353.5M |
| What was left | ||||
| Operating profit | $354.8M | $315.6M | $362.6M | $425.6M |
| Interest on debt | $10.7M | $10.5M | $7.7M | $10.2M |
| Profit before tax | $344.8M | $307.0M | $355.4M | $417.2M |
| Tax | $70.2M | $58.8M | $77.0M | $78.8M |
| Net profit | $274.6M | $248.2M | $278.4M | $338.4M |
| EBITDA | $392.1M | $356.2M | $400.9M | $468.5M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Engaging In Options Activity, Lawrence D Kingsley Exercises Options Valued At $873K In IDEXX Laboratories
NeutralSep 10Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock
BullishSep 10Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock
Leans bullishSep 10Is IDEXX Laboratories Stock Underperforming the Dow?
NeutralSep 10Idexx Laboratories stock hits 52-week low at $517.00 By Investing.com
Leans bullishSep 10Idexx Laboratories stock hits 52-week low at $517.00 By Investing.com
NeutralSep 9Idexx Laboratories stock hits 52-week low at $517.00
NeutralSep 9IDEXX Laboratories stock heads into the open after a modest gain
Leans bullishSep 9
Macro
32 macro signals shaping IDXX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results